Yearbook of pediatric endocrinology · 2020 · 11 citations · 0 references
Life SciencesBiochemistryNutritional SciencesLipid BiochemistryMetabolic RegulationMetabolismFatty Acid MetabolismInsulin ResistanceLipid DisordersLipid MetabolismLipid Metabolism DisordersMetabolic SyndromeCeramide BiosynthesisCeramide MetabolismDesaturase EnzymesHepatic Insulin ResistanceLipid DesaturationLipid Metabolism DisturbancesLipid Metabolism EffectsLipid Metabolism Pathways
By genetically engineering mice, the authors deleted the enzyme dihydroceramide desaturase 1 (DES1), which normally inserts a conserved double bond into the backbone of ceramides. Ablation of DES1 from whole animals or tissue-specific deletion in the liver and/or adipose tissue resolved hepatic steatosis and insulin resistance in mice caused by leptin deficiency or obesogenic diets